Division of Hematology & Oncology

Thank you for your interest in the Hematology/Oncology Division at the University of Virginia. We are delighted to serve our patients and families, our trainees, and our community. The Hematology/Oncology Division is devoted to state-of-the-art and compassionate treatment in malignant and non-malignant blood disorders, hemostasis and thrombosis, hematopoietic stem cell transplantation and cellular therapeutics, and solid tumor oncology. We are committed to improving care for the patients of tomorrow and have robust clinical trials and translational research programs. Our 35 hematologists/oncologists provide care at our outpatient facilities at the Emily Couric Clinical Cancer Center, or in our Community Oncology sites in Fishersville, Culpeper, and Charlottesville (Pantops location). We provide comprehensive care on our inpatient Hematology/Oncology and stem cell units, and on the hematology and oncology consultation services.

Division faculty are integral members of the UVA Health System’s Clinical Cancer Center as well as the NCI-designated Cancer Center, directed by Dr. Thomas Loughran, one of 70 such centers in the U.S. The Cancer Center remains in the top 50 US News & World Report rankings, putting us in the top 3% of cancer centers nationally. We are also the only cancer center in Virginia to be listed on Becker’s Hospital Review 100 Hospitals and Health Systems with great oncology programs for six consecutive years.

Our trainees enjoy a robust clinical and research experience dedicated to producing the next generation of hematologists/oncologists. We are dedicated to a diverse and safe environment for faculty and trainees.

Our cancer and blood disease multidisciplinary teams apply the latest diagnostic tools and molecular analytics to optimize treatment recommendations. We provide a robust portfolio of clinical trials that bring promising new agents to our patients, including cellular and immune-based therapy.  We offer a Sickle Cell Disease program and an Adult Comprehensive Bleeding Disorders Center to complement our long-standing excellence in the management of hemostatic and thrombotic disorders.

Our group is committed to providing the best in patient care, education and research, and to improving outcomes for patients with cancer and blood diseases. Please feel free to contact me if you wish to learn more about our Division or any of our programs.

Karen K. Ballen, MD
Cancer Center Distinguished Professorship
Chief, Hematology/Oncology Division
KB3TC@virginia.edu

Experimental Treatment Sends Deadly Leukemia into Remission

Dr. Thomas P. Loughran Jr., director of the University of Virginia Cancer Center, discusses an experimental new treatment approach for a rare, deadly leukemia that can send the disease into remission even in patients for whom the standard therapy has failed, buying them more time to have the stem cell transplant that could save their lives.

Learn More

Dr. Francine Garrett-Bakelman

A UVA Doctor Reflects on Her Work With NASA

NASA astronaut Scott Kelly came home from a yearlong stay on the International Space Station, and a young physician-scientist, Francine Garrett-Bakelman MD, PhD, was waiting anxiously. She had important work to do and only one shot to do it.
Read More

University of Virginia

233 UVA Physicians Selected for Best Doctors in America® List

11 Hematology/Oncology Physicians are among the 233 UVA Physicians Selected for Best Doctors in America® List.
Read More

Dr. Elizabeth Gaughan receives award

Hematology/Oncology Highlights

Notable achievements
See More

Inpatient Hematology and Oncology Moonlighting Information

Links to information and required paperwork for individuals who wish to moonlight.

Find Us On YouTube